ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
iSERA Lifesciences approved a name change from Covidh Technologies and adopted a new logo. The Board also addressed BSE advisory matters regarding regulatory non-compliance.
iSERA Lifesciences Limited approved the acquisition of 100% stake in iSERA Biological Limited for ₹78 Crore via a share swap. The board also approved increasing authorised share capital to ₹25 Crore and adopting a new Memorandum and Articles of Association. The acquisition will make iSERA Biological a wholly-owned subsidiary, creating strategic synergies in the pharmaceutical sector.
iSERA Lifesciences Limited has scheduled a Board Meeting on April 20, 2026. The board will consider and approve a preferential issue of equity shares on a private placement basis. This move indicates the company's intent to raise capital for strategic purposes.